Pancreas-enriched miRNA refines endocrine cell differentiation

Development (Cambridge)

Volumn 139, Issue 16, 2012, Pages 3021-3031

  Kredo Russo, Sharon ^a   Mandelbaum, Amitai D ^a   Ness, Avital ^a   Alon, Ilana ^a   Lennox, Kim A ^b   Behlke, Mark A ^b   Hornstein, Eran ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^b INTEGRATED DNA TECHNOLOGIES   (United States)

Author keywords

cell; microRNA; miR 7; Mouse; Pancreas development; Pax6

Indexed keywords

INSULIN; MICRORNA; MICRORNA 7; TRANSCRIPTION FACTOR PAX6; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CELL MATURATION; CONTROLLED STUDY; DOWN REGULATION; EMBRYO; ENDOCRINE CELL; EXPLANT; GENE OVEREXPRESSION; GENE SILENCING; HAPLOINSUFFICIENCY; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PANCREAS ISLET ALPHA CELL; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN TARGETING; STEM CELL; TRANSGENIC MOUSE;

ANIMALS; BASE SEQUENCE; CELL DIFFERENTIATION; EYE PROTEINS; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENE KNOCKDOWN TECHNIQUES; HAPLOINSUFFICIENCY; HOMEODOMAIN PROTEINS; INSULIN; ISLETS OF LANGERHANS; MICE; MICE, INBRED ICR; MICE, TRANSGENIC; MICRORNAS; MODELS, BIOLOGICAL; ORGAN CULTURE TECHNIQUES; PAIRED BOX TRANSCRIPTION FACTORS; PANCREAS; PROMOTER REGIONS, GENETIC; REPRESSOR PROTEINS; RNA, MESSENGER; UP-REGULATION;

MUS MUSCULUS;

EID: 84864305807     PISSN: 09501991     EISSN: 14779129     Source Type: Journal    
DOI: 10.1242/dev.080127     Document Type: Article

References (51)

1. Ashery-Padan, R., Zhou, X., Marquardt, T., Herrera, P., Toube, L., Berry, A. and Gruss, P. (2004). Conditional inactivation of Pax6 in the pancreas causes early onset of diabetes. Dev. Biol. 269, 479-488.
2. Avnit-Sagi, T., Kantorovich, L., Kredo-Russo, S., Hornstein, E. and Walker, M. D. (2009). The promoter of the pri-miR-375 gene directs expression selectively to the endocrine pancreas. PLoS ONE 4, e5033.
3. Bartel, D. P. (2004). MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116, 281-297.
4. Baulmann, D. C., Ohlmann, A., Flugel-Koch, C., Goswami, S., Cvekl, A. and Tamm, E. R. (2002). Pax6 heterozygous eyes show defects in chamber angle differentiation that are associated with a wide spectrum of other anterior eye segment abnormalities. Mech. Dev. 118, 3-17.
5. Berger, J., Berger, S., Tuoc, T. C., D'Amelio, M., Cecconi, F., Gorski, J. A., Jones, K. R., Gruss, P. and Stoykova, A. (2007). Conditional activation of Pax6 in the developing cortex of transgenic mice causes progenitor apoptosis. Development 134, 1311-1322.
6. Bonal, C. and Herrera, P. L. (2008). Genes controlling pancreas ontogeny. Int. J. Dev. Biol. 52, 823-835.
7. Bravo-Egana, V., Rosero, S., Molano, R. D., Pileggi, A., Ricordi, C., Dominguez-Bendala, J. and Pastori, R. L. (2008). Quantitative differential expression analysis reveals miR-7 as major islet microRNA. Biochem. Biophys. Res. Commun. 366, 922-926.
8. Collinson, J. M., Quinn, J. C., Buchanan, M. A., Kaufman, M. H., Wedden, S. E., West, J. D. and Hill, R. E. (2001). Primary defects in the lens underlie complex anterior segment abnormalities of the Pax6 heterozygous eye. Proc. Natl. Acad. Sci. USA 98, 9688-9693.
9. Collombat, P., Mansouri, A., Hecksher-Sorensen, J., Serup, P., Krull, J., Gradwohl, G. and Gruss, P. (2003). Opposing actions of Arx and Pax4 in endocrine pancreas development. Genes Dev. 17, 2591-2603.
10. Correa-Medina, M., Bravo-Egana, V., Rosero, S., Ricordi, C., Edlund, H., Diez, J. and Pastori, R. L. (2009). MicroRNA miR-7 is preferentially expressed in endocrine cells of the developing and adult human pancreas. Gene Expr. Patterns 9, 193-199.
11. Dames, P., Puff, R., Weise, M., Parhofer, K. G., Goke, B., Gotz, M., Graw, J., Favor, J. and Lechner, A. (2010). Relative roles of the different Pax6 domains for pancreatic alpha cell development. BMC Dev. Biol. 10, 39.
12. Dennis, G., Jr, Sherman, B. T., Hosack, D. A., Yang, J., Gao, W., Lane, H. C. and Lempicki, R. A. (2003). DAVID: database for annotation, visualization, and integrated discovery. Genome Biol. 4, P3.
13. Ding, J., Gao, Y., Zhao, J., Yan, H., Guo, S. Y., Zhang, Q. X., Li, L. S. and Gao, X. (2009). Pax6 haploinsufficiency causes abnormal metabolic homeostasis by down-regulating glucagon-like peptide 1 in mice. Endocrinology 150, 2136-2144.
14. Gradwohl, G., Dierich, A., LeMeur, M. and Guillemot, F. (2000). neurogenin3 is required for the development of the four endocrine cell lineages of the pancreas. Proc. Natl. Acad. Sci. USA 97, 1607-1611.
15. Gu, G., Dubauskaite, J. and Melton, D. A. (2002). Direct evidence for the pancreatic lineage: NGN3+ cells are islet progenitors and are distinct from duct progenitors. Development 129, 2447-2457.
16. Gunawardana, S. C., Hara, M., Bell, G. I., Head, W. S., Magnuson, M. A. and Piston, D. W. (2005). Imaging Beta cell development in real-time using pancreatic explants from mice with green fluorescent protein-labeled pancreatic Beta cells. In Vitro Cell. Dev. Biol. Anim. 41, 7-11.
17. Heller, R. S., Stoffers, D. A., Liu, A., Schedl, A., Crenshaw, E. B., 3rd, Madsen, O. D. and Serup, P. (2004). The role of Brn4/Pou3f4 and Pax6 in forming the pancreatic glucagon cell identity. Dev. Biol. 268, 123-134.
18. Heller, R. S., Jenny, M., Collombat, P., Mansouri, A., Tomasetto, C., Madsen, O. D., Mellitzer, G., Gradwohl, G. and Serup, P. (2005). Genetic determinants of pancreatic epsilon-cell development. Dev. Biol. 286, 217-224.
19. Hornstein, E. and Shomron, N. (2006). Canalization of development by microRNAs. Nat. Genet. 38 Suppl., S20-S24.
20. Jan, C. H., Friedman, R. C., Ruby, J. G. and Bartel, D. P. (2011). Formation, regulation and evolution of Caenorhabditis elegans 3′UTRs. Nature 469, 97-101.
21. Jensen, J., Heller, R. S., Funder-Nielsen, T., Pedersen, E. E., Lindsell, C., Weinmaster, G., Madsen, O. D. and Serup, P. (2000). Independent development of pancreatic alpha- and beta-cells from neurogenin3-expressing precursors: a role for the notch pathway in repression of premature differentiation. Diabetes 49, 163-176.
22. Kefas, B., Godlewski, J., Comeau, L., Li, Y., Abounader, R., Hawkinson, M., Lee, J., Fine, H., Chiocca, E. A., Lawler, S. et al. (2008). microRNA-7 inhibits the epidermal growth factor receptor and the Akt pathway and is downregulated in glioblastoma. Cancer Res. 68, 3566-3572.
23. Kloosterman, W. P., Lagendijk, A. K., Ketting, R. F., Moulton, J. D. and Plasterk, R. H. (2007). Targeted inhibition of miRNA maturation with morpholinos reveals a role for miR-375 in pancreatic islet development. PLoS Biol. 5, e203.
24. Kredo-Russo, S. and Hornstein, E. (2011). MicroRNA knock down by cholesterol-conjugated antisense oligos in mouse organ culture. Methods Mol. Biol. 732, 89-97.
25. Kroeber, M., Davis, N., Holzmann, S., Kritzenberger, M., Shelah-Goraly, M., Ofri, R., Ashery-Padan, R. and Tamm, E. R. (2010). Reduced expression of Pax6 in lens and cornea of mutant mice leads to failure of chamber angle development and juvenile glaucoma. Hum. Mol. Genet. 19, 3332-3342.
26. Landgraf, P., Rusu, M., Sheridan, R., Sewer, A., Iovino, N., Aravin, A., Pfeffer, S., Rice, A., Kamphorst, A. O., Landthaler, M. et al. (2007). A mammalian microRNA expression atlas based on small RNA library sequencing. Cell 129, 1401-1414.
27. Lewis, B. P., Burge, C. B. and Bartel, D. P. (2005). Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120, 15-20.
28. Li, X., Cassidy, J. J., Reinke, C. A., Fischboeck, S. and Carthew, R. W. (2009). A microRNA imparts robustness against environmental fluctuation during development. Cell 137, 273-282.
29. Lynn, F. C., Skewes-Cox, P., Kosaka, Y., McManus, M. T., Harfe, B. D. and German, M. S. (2007). MicroRNA expression is required for pancreatic islet cell genesis in the mouse. Diabetes 56, 2938-2945.
30. Lyttle, B. M., Li, J., Krishnamurthy, M., Fellows, F., Wheeler, M. B., Goodyer, C. G. and Wang, R. (2008). Transcription factor expression in the developing human fetal endocrine pancreas. Diabetologia 51, 1169-1180.
31. Martin, M., Hauer, V., Messmer, M., Orvain, C. and Gradwohl, G. (2007). Transcription factors in pancreatic development. Animal models. Endocr. Dev. 12, 24-32.
32. Melkman-Zehavi, T., Oren, R., Kredo-Russo, S., Shapira, T., Mandelbaum, A. D., Rivkin, N., Nir, T., Lennox, K. A., Behlke, M. A., Dor, Y. et al. (2011). miRNAs control insulin content in pancreatic beta-cells via downregulation of transcriptional repressors. EMBO J. 30, 835-845.
33. Murtaugh, L. C. and Melton, D. A. (2003). Genes, signals, and lineages in pancreas development. Annu. Rev. Cell Dev. Biol. 19, 71-89.
34. Nishimura, W., Rowan, S., Salameh, T., Maas, R. L., Bonner-Weir, S., Sell, S. M. and Sharma, A. (2008). Preferential reduction of beta cells derived from Pax6-MafB pathway in MafB deficient mice. Dev. Biol. 314, 443-456.
35. Pena, J. T., Sohn-Lee, C., Rouhanifard, S. H., Ludwig, J., Hafner, M., Mihailovic, A., Lim, C., Holoch, D., Berninger, P., Zavolan, M. et al. (2009). miRNA in situ hybridization in formaldehyde and EDC-fixed tissues. Nat. Methods 6, 139-141.
36. Poy, M. N., Eliasson, L., Krutzfeldt, J., Kuwajima, S., Ma, X., Macdonald, P. E., Pfeffer, S., Tuschl, T., Rajewsky, N., Rorsman, P. et al. (2004). A pancreatic islet-specific microRNA regulates insulin secretion. Nature 432, 226-230.
37. Poy, M. N., Hausser, J., Trajkovski, M., Braun, M., Collins, S., Rorsman, P., Zavolan, M. and Stoffel, M. (2009). miR-375 maintains normal pancreatic alpha- and beta-cell mass. Proc. Natl. Acad. Sci. USA 106, 5813-5818.
38. Sander, M., Neubuser, A., Kalamaras, J., Ee, H. C., Martin, G. R. and German, M. S. (1997). Genetic analysis reveals that PAX6 is required for normal transcription of pancreatic hormone genes and islet development. Genes Dev. 11, 1662-1673.
39. Schedl, A., Ross, A., Lee, M., Engelkamp, D., Rashbass, P., van Heyningen, V. and Hastie, N. D. (1996). Influence of PAX6 gene dosage on development: overexpression causes severe eye abnormalities. Cell 86, 71-82.
40. Silahtaroglu, A. N., Nolting, D., Dyrskjot, L., Berezikov, E., Moller, M., Tommerup, N. and Kauppinen, S. (2007). Detection of microRNAs in frozen tissue sections by fluorescence in situ hybridization using locked nucleic acid probes and tyramide signal amplification. Nat. Protoc. 2, 2520-2528.
41. Smith, S. B., Ee, H. C., Conners, J. R. and German, M. S. (1999). Paired-homeodomain transcription factor PAX4 acts as a transcriptional repressor in early pancreatic development. Mol. Cell. Biol. 19, 8272-8280.
42. Srinivas, S., Watanabe, T., Lin, C. S., William, C. M., Tanabe, Y., Jessell, T. M. and Costantini, F. (2001). Cre reporter strains produced by targeted insertion of EYFP and ECFP into the ROSA26 locus. BMC Dev. Biol. 1, 4.
43. St-Onge, L., Sosa-Pineda, B., Chowdhury, K., Mansouri, A. and Gruss, P. (1997). Pax6 is required for differentiation of glucagon-producing alpha-cells in mouse pancreas. Nature 387, 406-409.
44. Stark, A., Brennecke, J., Bushati, N., Russell, R. B. and Cohen, S. M. (2005). Animal MicroRNAs confer robustness to gene expression and have a significant impact on 3′UTR evolution. Cell 123, 1133-1146.
45. Tkatchenko, A. V. (2006). Whole-mount BrdU staining of proliferating cells by DNase treatment: application to postnatal mammalian retina. Biotechniques 40, 29-30, 32.
46. van Raamsdonk, C. D. and Tilghman, S. M. (2000). Dosage requirement and allelic expression of PAX6 during lens placode formation. Development 127, 5439-5448.
47. Wang, S., Yan, J., Anderson, D. A., Xu, Y., Kanal, M. C., Cao, Z., Wright, C. V. and Gu, G. (2010). Neurog3 gene dosage regulates allocation of endocrine and exocrine cell fates in the developing mouse pancreas. Dev. Biol. 339, 26-37.
48. Wienholds, E., Kloosterman, W. P., Miska, E., Alvarez-Saavedra, E., Berezikov, E., de Bruijn, E., Horvitz, H. R., Kauppinen, S. and Plasterk, R. H. (2005). MicroRNA expression in zebrafish embryonic development. Science 309, 310-311.
49. Yamaoka, T., Yano, M., Yamada, T., Matsushita, T., Moritani, M., Ii, S., Yoshimoto, K., Hata, J. and Itakura, M. (2000). Diabetes and pancreatic tumours in transgenic mice expressing Pax 6. Diabetologia 43, 332-339.
50. Yasuda, T., Kajimoto, Y., Fujitani, Y., Watada, H., Yamamoto, S., Watarai, T., Umayahara, Y., Matsuhisa, M., Gorogawa, S., Kuwayama, Y. et al. (2002). PAX6 mutation as a genetic factor common to aniridia and glucose intolerance. Diabetes 51, 224-230.
51. Zhou, Q., Law, A. C., Rajagopal, J., Anderson, W. J., Gray, P. A. and Melton, D. A. (2007). A multipotent progenitor domain guides pancreatic organogenesis. Dev. Cell 13, 103-114.